Pandemic
Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat Biotech
WTO clinches deal on fisheries subsidies; agrees for patent waiver for Covid vaccines
RBI not behind the curve; tolerance of high inflation was a necessity: Das
Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/post_banners/poaIxfDdBmIoBFhkfgBC.jpg)
/newsdrum-in/media/post_banners/JhzTMdy3rz1fcDdjYBs1.jpg)
/newsdrum-in/media/post_banners/weLEhn3rhM5D4Pup2rY5.jpg)
/newsdrum-in/media/post_banners/gRtX6WZvGETc8QGl4cQa.jpg)
/newsdrum-in/media/post_banners/hMBwmegh6zwzalPxYMn4.jpg)
/newsdrum-in/media/post_banners/vFmkuy7jbcV0gBzeExQ2.jpg)
/newsdrum-in/media/post_banners/9DGIYmepB58FvksdiqbL.jpg)
/newsdrum-in/media/post_banners/cbHfG4SE21amd7imMxrc.jpg)
/newsdrum-in/media/post_banners/0RDkcVLYrUHgN1B2bRRh.jpg)
/newsdrum-in/media/post_banners/EaZr5hfXlufShtHcDWjb.jpg)
